BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37629773)

  • 1. Clinical Research in Chronic Lymphocytic Leukemia in Pakistan; A Systematic Review.
    Ammad Ud Din M; Shahzad M; Ashraf A; Liaqat H; Jaan A; Anwer F
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629773
    [No Abstract]   [Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicohematological parameters and outcomes in a cohort of chronic lymphocytic leukemia patients with Deletion 17p from Pakistan.
    Mahmood R; Khan SA; Altaf C; Malik HS; Khadim MT
    Blood Res; 2018 Dec; 53(4):276-280. PubMed ID: 30588463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency Of TP53 Gene Mutation In Patients With Chronic Lymphocytic Leukaemia.
    Qadir H; Nasir N; Qadir N; Adil SN; Tanzeem H; Qadir A
    J Ayub Med Coll Abbottabad; 2020; 32(4):523-526. PubMed ID: 33225656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization.
    Gerrie AS; Huang SJ; Bruyere H; Dalal C; Hrynchak M; Karsan A; Ramadan KM; Smith AC; Tyson C; Toze CL; Gillan TL
    Cancer Genet; 2014; 207(7-8):316-25. PubMed ID: 25441686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
    Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
    Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
    Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials.
    Ntsethe A; Dludla PV; Nyambuya TM; Ngcobo SR; Nkambule BB
    Medicine (Baltimore); 2020 Jul; 99(28):e21167. PubMed ID: 32664154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence--clinical implication and comparison between the West and the East.
    Wu SJ; Lin CT; Huang SY; Lee FY; Liu MC; Hou HA; Chen CY; Ko BS; Chou WC; Yao M; Tang JL; Tsay W; Tien HF
    Ann Hematol; 2013 Jun; 92(6):799-806. PubMed ID: 23417757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
    Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
    Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients.
    Doneda L; Montillo M; Intropido L; Tedeschi A; Morra E; Larizza L
    Cancer Genet Cytogenet; 2003 Jan; 140(1):31-6. PubMed ID: 12550755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of comparative genomic hybridization and fluorescence in situ hybridization to the detection of chromosomal abnormalities in B-cell chronic lymphocytic leukemia.
    Jarosová M; Jedlicková K; Holzerová M; Urbanová R; Papajík T; Raida L; Pikalová Z; Lakomá I; Prekopová I; Kropácková J; Indrák K
    Onkologie; 2001 Feb; 24(1):60-5. PubMed ID: 11441283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Chromosomal Abnormalities in Tissues Involved by Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Horna P; Pearce KE; Ketterling RP; Shi M; Peterson JF
    Am J Clin Pathol; 2022 Feb; 157(2):286-292. PubMed ID: 34528680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
    Glassman AB; Hayes KJ
    Cancer Genet Cytogenet; 2005 Apr; 158(1):88-91. PubMed ID: 15771912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.